Human Endothelial Cell-specific Molecule 1, ESM-1 ELISA Kit

Overview:

Target Protein: Endothelial Cell-Specific Molecule 1, ESM1

Size: 48T, 96T

Assay Type: Sandwich

One-Step: -

Sensitivity: 2.56ng/L

Detection range: 5-2000ng/L

Sample type: Serum, plasma, cell culture supernates

Reactive with: Human

Storage: 2 - 8°C

Assay Time: 1:30 h

Detailed Information:

Involved in angiogenesis; promotes angiogenic sprouting. May have potent implications in lung endothelial cell-leukocyte interactions.

ESM1 Information:

UniProt Accession: Q9NQ30

Synonyms: Endothelial cell-specific molecule 1;ESM 1;ESM1;ESM-1

References:

• Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases Journal: Int J Clin Pract. 2022 Jul 13;2022:4524637
• Can the Serum Endocan Level Be Used as a Biomarker to Predict Subclinical Atherosclerosis in Patients with Prediabetes? Journal: Arq Bras Cardiol. 2022 Oct;119(4):544-550. English, Portuguese.
• A Comparison of the Circulating Endocan Levels between the Inflammatory and Malignant Diseases of the Same Organ: The Breast Journal: J Invest Surg. 2021 Nov;34(11):1207-1213.
• Serum Endocan Levels and Subclinical Atherosclerosis in Behçet's Syndrome Journal: Int J Gen Med. 2022 Aug 18;15:6653-6659.
• Evaluation of arterial stiffness and serum endocan levels in patients with primary aldosteronism with new-onset hypertension and long-term hypertension Journal: J Endocrinol Invest. 2023 Jan;46(1):103-110.
• Role of endothelial cell specific molecule-1 (endocan) and cardiac imaging in early detection of cardiac involvement in psoriatic patients with or without arthritis Journal: The Egyptian Rheumatologist,Volume 44, Issue 2,2022,Pages 159-164
• Evaluation of subclinical atherosclerosis in obese patients with three noninvasive methods: Arterial stiffness, carotid intima-media thickness, and biomarkers of endothelial dysfunction Journal: Arch Endocrinol Metab. 2023 May 12;67(4):e000622.
• Arterial Stiffness, Carotid Intima-Media Thickness, Endocan, and A Disintegrin and Metalloproteinase With Thrombospondin Type I Motif 9 Levels and Their Relationship With Disease Activity in Patients With Acromegaly With and Without Cardiovascular Risk Factors Journal: Endocr Pract. 2022 Mar;28(3):298-303.
• Endocan: A novel biomarker of endothelial dysfunction in depression? Journal: J Psychiatr Res. 2023 Sep;165:219-224.

Supplier: BT-Labs